Acute Cardiovascular Events Triggered by COVID-19-Related Stress
NCT04368637 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2020-05-05
Summary
The current COVID19 pandemic has afflicted almost the whole globe. The stress related to the pandemic, not the direct virus-related injury, can be potentially associated with acute cardiovascular events due to a large list of physical and psychosocial stresses.
This study is a cross sectional study that will enroll patients evaluated during the COVID19 pandemic period for acute cardiovascular events.
Conditions
- Acute Myocardial Infarction
- Ventricular Tachycardia
- Sudden Cardiac Death
- Stroke, Acute
Sponsors & Collaborators
-
Jordan Collaborating Cardiology Group
lead OTHER
Principal Investigators
-
Ayman J Hammoudeh, MD, FACC · JCC Group
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-03
- Primary Completion
- 2020-07-30
- Completion
- 2020-08-30
Countries
- Jordan
Study Locations
More Related Trials
-
Post-Acute Sequelae of Coronavirus-19 (COVID-19) With Dyspnea on Exertion And Associated TaChycardia TrEatment Study
NCT05096884 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy
NCT05961202 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers
NCT04795479 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19
NCT04374110 ·Status: UNKNOWN
-
Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI
NCT07138508 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts
NCT04652648 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction
NCT04308031 ·Status: UNKNOWN ·Phase: PHASE3
-
Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina
NCT01396395 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure
NCT04468529 ·Status: COMPLETED ·Phase: PHASE3
-
Adrecizumab in Cardiogenic Shock
NCT03989531 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers
NCT03012828 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating DyNamic Myocardial Blood Flow QUantitation As a Cost Effective Care ModeL for DiabEtic Patients With Coronary Artery DiSease
NCT05343884 ·Status: RECRUITING ·Phase: NA
-
Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway
NCT05610423 ·Status: ENROLLING_BY_INVITATION
-
Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)
NCT04762771 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Sodium Nitrite in Acute Myocardial Infarction
NCT00924118 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm
NCT00007605 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
NCT05350969 ·Status: COMPLETED ·Phase: PHASE2
-
Monitoring Drug-induced Myocarditis (CardiTOX)
NCT03855982 ·Status: COMPLETED
-
Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
NCT05619653 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Value of Heart Rate Lowering Therapy in Acute Myocarditis
NCT06312891 ·Status: RECRUITING
-
Adrenaline for the Treatment of No-Reflow in Normotensive Patients
NCT04699110 ·Status: COMPLETED ·Phase: PHASE4
-
Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support
NCT05594342 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Trial of Human (Allogeneic) iPS Cell-derived Cardiomyocytes Sheet for Ischemic Cardiomyopathy
NCT04696328 ·Status: UNKNOWN ·Phase: PHASE1
-
Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"
NCT04403100 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers
NCT02910635 ·Status: COMPLETED ·Phase: PHASE1